VF
UNCY icon

Virtu Financial’s Unicycive Therapeutics UNCY Stock Holding History

Virtu Financial’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$173K Buy
+26,274
New +$172K 0.01% 1059
2025
Q2 		– Sell
-3,887
Closed -$22K – 2047
2025
Q1 		$22K Buy
+3,887
New +$23.7K ﹤0.01% 1096
2024
Q4 		– Sell
-7,398
Closed -$30K – 2080
2024
Q3 		$30K Buy
7,398
+6,289
+567% +$25.3K ﹤0.01% 1085
2024
Q2 		$6K Sell
1,109
-1,499
-57% -$14.7K ﹤0.01% 1176
2024
Q1 		$36K Buy
+2,608
New +$31.6K ﹤0.01% 1077
2023
Q4 		– Sell
-1,099
Closed -$9K – 2027
2023
Q3 		$9K Buy
+1,099
New +$10.3K ﹤0.01% 1119
2023
Q1 		– Sell
-1,546
Closed -$8K – 2123
2022
Q4 		$8K Buy
+1,546
New +$10.5K ﹤0.01% 1414

Other funds holding UNCY

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial's UNCY Position: Q1 2026 in Review

Virtu Financial opened a new position in Unicycive Therapeutics (UNCY) in Q1 2026: 26,274 shares worth $173K. The stake represents 0.01% of the portfolio and ranks #1059 among its holdings. This is a return to the name: Virtu Financial previously reported a position in UNCY as recently as Q1 2025.

Virtu Financial first reported a position in UNCY in Q4 2022 and has held it in 7 quarters since. 51 funds tracked by Wall St. Rank hold UNCY as of Q1 2026.

  • Virtu Financial held 26,274 shares of Unicycive Therapeutics worth $173K as of Q1 2026.
  • Unicycive Therapeutics was a new Virtu Financial position in Q1 2026.
  • Unicycive Therapeutics made up 0.01% of Virtu Financial's portfolio in Q1 2026, its #1059 holding.
  • Virtu Financial first reported a position in Unicycive Therapeutics in Q4 2022 and has held it in 7 quarters since.
  • 51 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.